Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Phase III Trial With a PET Response Adapted Design Comparing ABVD +/- ISRT With A2VD +/- ISRT in Patients With Previously Untreated Stage IA/IIA Hodgkin Lymphoma

NCT04685616 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT04685616
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04685616 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Phase III Trial With a PET Response Adapted Design Comparing ABVD +/- ISRT With A2VD +/- ISRT in Patients With Previously Untreated Stage IA/IIA Hodgkin Lymphoma
Lead sponsor
University College, London
Phase
Phase 3
Overall status
Recruiting
Start date
April 14, 2022
Completion date
September 30, 2032
Enrollment
1,042 (estimated)
Sites
72

Conditions

As the registry lists them; a condition with its own page is linked.

hodgkin lymphoma